Parallax Volatility Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,161
| Closed | -$5.45M | – | 548 |
|
|
2024
Q4 | $5.45M | Sell |
23,161
-3,374
| -13% | -$794K | 0.01% | 165 |
|
|
2024
Q3 | $7.3M | Buy |
+26,535
| New | +$7.3M | 0.01% | 109 |
|
|
2024
Q2 | – | Sell |
-2,237
| Closed | -$334K | – | 620 |
|
|
2024
Q1 | $334K | Buy |
+2,237
| New | +$334K | ﹤0.01% | 407 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 915 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 949 |
|
|
2022
Q3 | – | Sell |
-12,781
| Closed | -$1.86M | – | 1038 |
|
|
2022
Q2 | $1.86M | Buy |
+12,781
| New | +$1.86M | ﹤0.01% | 298 |
|
|
2020
Q4 | – | Sell |
-15,460
| Closed | -$2.25M | – | 902 |
|
|
2020
Q3 | $2.25M | Buy |
15,460
+11,746
| +316% | +$1.71M | ﹤0.01% | 442 |
|
|
2020
Q2 | $550K | Buy |
3,714
+2,260
| +155% | +$335K | ﹤0.01% | 604 |
|
|
2020
Q1 | $158K | Sell |
1,454
-1,250
| -46% | -$136K | ﹤0.01% | 734 |
|
|
2019
Q4 | $311K | Buy |
+2,704
| New | +$311K | ﹤0.01% | 610 |
|
|
2019
Q3 | – | Sell |
-157
| Closed | -$11K | – | 889 |
|
|
2019
Q2 | $11K | Sell |
157
-28
| -15% | -$1.96K | ﹤0.01% | 803 |
|
|
2019
Q1 | $17K | Sell |
185
-4,046
| -96% | -$372K | ﹤0.01% | 1140 |
|
|
2018
Q4 | $308K | Sell |
4,231
-596
| -12% | -$43.4K | ﹤0.01% | 533 |
|
|
2018
Q3 | $422K | Sell |
4,827
-6,714
| -58% | -$587K | ﹤0.01% | 366 |
|
|
2018
Q2 | $1.14M | Buy |
+11,541
| New | +$1.14M | ﹤0.01% | 256 |
|
|
2018
Q1 | – | Sell |
-299
| Closed | -$38K | – | 1263 |
|
|
2017
Q4 | $38K | Sell |
299
-45,091
| -99% | -$5.73M | ﹤0.01% | 2226 |
|
|
2017
Q3 | $5.33M | Buy |
+45,390
| New | +$5.33M | 0.01% | 88 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 757 |
|
|
2015
Q4 | – | Sell |
-1,500
| Closed | -$121K | – | 877 |
|
|
2015
Q3 | $121K | Hold |
1,500
| – | – | ﹤0.01% | 528 |
|
|
2015
Q2 | $180K | Buy |
+1,500
| New | +$180K | ﹤0.01% | 584 |
|